-
1
-
-
79751499344
-
The relationship between inflammation, platelet activation and antiplatelet resistance
-
Acikel S, Akdemir R. The relationship between inflammation, platelet activation and antiplatelet resistance. Inflamm Allergy Drug Targets 2010; 9: 364-81.
-
(2010)
Inflamm Allergy Drug Targets
, vol.9
, pp. 364-381
-
-
Acikel, S.1
Akdemir, R.2
-
2
-
-
3042537320
-
The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?
-
Altman R, Luciardi H, Muntaner J, Herrera RN. The antithrombotic profile of aspirin. Aspirin resistance, or simply failure? Thromb J 2004; 2: 1-8.
-
(2004)
Thromb J
, vol.2
, pp. 1-8
-
-
Altman, R.1
Luciardi, H.2
Muntaner, J.3
Herrera, R.N.4
-
3
-
-
77949543832
-
Platelet hyporesponsiveness to acetylsalicylic acid can be transferred by plasma in humans
-
Anger K, Kempfert J, Kostelka M, Mohr FW, Dhein S. Platelet hyporesponsiveness to acetylsalicylic acid can be transferred by plasma in humans. Pharmacology 2010; 85: 241-7.
-
(2010)
Pharmacology
, vol.85
, pp. 241-247
-
-
Anger, K.1
Kempfert, J.2
Kostelka, M.3
Mohr, F.W.4
Dhein, S.5
-
4
-
-
73949157474
-
Platelet thrombin receptor antagonism and atherothrombosis
-
Angiolillo DJ, Capodanno D, Goto S. Platelet thrombin receptor antagonism and atherothrombosis. Eur Heart J 2010; 31: 17-28.
-
(2010)
Eur Heart J
, vol.31
, pp. 17-28
-
-
Angiolillo, D.J.1
Capodanno, D.2
Goto, S.3
-
5
-
-
0037065502
-
Collaborative metaanalysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients
-
Antithrombotic Trialists Collaboration
-
Antithrombotic Trialists Collaboration. Collaborative metaanalysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002; 324: 71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
6
-
-
80051800551
-
Platelet response to aspirin 50 and 100 mg in patients with coronary heart disease over a five-year period
-
Berent R, Auer J, Franklin B, Schmid P, von Duvillard SP. Platelet response to aspirin 50 and 100 mg in patients with coronary heart disease over a five-year period. Am J Cardiol 2011; 108: 644-50.
-
(2011)
Am J Cardiol
, vol.108
, pp. 644-650
-
-
Berent, R.1
Auer, J.2
Franklin, B.3
Schmid, P.4
von Duvillard, S.P.5
-
7
-
-
33750924102
-
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
-
Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-74.
-
(2006)
Eur Heart J
, vol.27
, pp. 2667-2674
-
-
Biondi-Zoccai, G.G.1
Lotrionte, M.2
Agostoni, P.3
Abbate, A.4
Fusaro, M.5
Burzotta, F.6
Testa, L.7
Sheiban, I.8
Sangiorgi, G.9
-
9
-
-
77952037162
-
Effect of obesity on platelet reactivity and response to low-dose aspirin
-
Bordeaux BC, Qayyum R, Yanek LR, Vaidya D, Becker LC, Faraday N, Becker DM. Effect of obesity on platelet reactivity and response to low-dose aspirin. Prev Cardiol 2010; 13: 56-62.
-
(2010)
Prev Cardiol
, vol.13
, pp. 56-62
-
-
Bordeaux, B.C.1
Qayyum, R.2
Yanek, L.R.3
Vaidya, D.4
Becker, L.C.5
Faraday, N.6
Becker, D.M.7
-
10
-
-
0346367328
-
Aggregation of blood platelets by adenosine diphosphate and its reversal
-
Born GR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
-
(1962)
Nature
, vol.194
, pp. 927-929
-
-
Born, G.R.1
-
12
-
-
0035924765
-
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
-
Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, Fitzgerald GA. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin, N Engl J Med 2001; 345: 1809-17.
-
(2001)
N Engl J Med
, vol.345
, pp. 1809-1817
-
-
Catella-Lawson, F.1
Reilly, M.P.2
Kapoor, S.C.3
Cucchiara, A.J.4
DeMarco, S.5
Tournier, B.6
Vyas, S.N.7
Fitzgerald, G.A.8
-
13
-
-
33747168513
-
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers
-
Cox D, Maree AO, Dooley M, Conroy R, Byrne MF, Fitzgerald DJ. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke 2006, 37: 2153-8.
-
(2006)
Stroke
, vol.37
, pp. 2153-2158
-
-
Cox, D.1
Maree, A.O.2
Dooley, M.3
Conroy, R.4
Byrne, M.F.5
Fitzgerald, D.J.6
-
14
-
-
0037015289
-
Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptordeficient mice
-
Cyrus T, Sung S, Zhao L, Funk CD, Tang S, Praticò D. Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptordeficient mice. Circulation 2002; 106: 1282-7.
-
(2002)
Circulation
, vol.106
, pp. 1282-1287
-
-
Cyrus, T.1
Sung, S.2
Zhao, L.3
Funk, C.D.4
Tang, S.5
Praticò, D.6
-
15
-
-
0037046196
-
Aspirinresistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
-
Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirinresistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650-5.
-
(2002)
Circulation
, vol.105
, pp. 1650-1655
-
-
Eikelboom, J.W.1
Hirsh, J.2
Weitz, J.I.3
Johnston, M.4
Yi, Q.5
Yusuf, S.6
-
16
-
-
0035875796
-
2 concentrations: A placebo-controlled study using a highly sensitive C-reactive protein assay
-
2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 2001; 37: 2036-41.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 2036-2041
-
-
Feldman, M.1
Jialal, I.2
Devaraj, S.3
Cryer, B.4
-
17
-
-
0020692577
-
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
-
Fitzgerald GA, Brash AR, Oates JA, Pedersen AK. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983; 71: 678-88.
-
(1983)
J Clin Invest
, vol.71
, pp. 678-688
-
-
Fitzgerald, G.A.1
Brash, A.R.2
Oates, J.A.3
Pedersen, A.K.4
-
18
-
-
33747088257
-
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway: A 700-patient study of aspirin resistance
-
Frelinger AL 3rd, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Circulation 2006; 113: 2888-96.
-
(2006)
Circulation
, vol.113
, pp. 2888-2896
-
-
Frelinger III, A.L.1
Furman, M.I.2
Linden, M.D.3
Li, Y.4
Fox, M.L.5
Barnard, M.R.6
Michelson, A.D.7
-
19
-
-
67949083606
-
Aspirin reduces the prothrombotic activity of C-reactive protein
-
Grad E, Golomb M, Koroukhov N, Lawson JA, Lotan C, Fitzgerald GA, Danenberg HD. Aspirin reduces the prothrombotic activity of C-reactive protein. J Thromb Haemost 2009; 7: 1393-400.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1393-1400
-
-
Grad, E.1
Golomb, M.2
Koroukhov, N.3
Lawson, J.A.4
Lotan, C.5
Fitzgerald, G.A.6
Danenberg, H.D.7
-
20
-
-
77953160638
-
A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease
-
Grove EL, Hvas AM, Johnsen HL, Hedegaard SS, Pedersen SB, Mortensen J, Kristensen SD. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost 2010; 103: 1245-53.
-
(2010)
Thromb Haemost
, vol.103
, pp. 1245-1253
-
-
Grove, E.L.1
Hvas, A.M.2
Johnsen, H.L.3
Hedegaard, S.S.4
Pedersen, S.B.5
Mortensen, J.6
Kristensen, S.D.7
-
21
-
-
78650952436
-
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease
-
Grove EL, Hvas AM, Mortensen SB, Larsen SB, Kristensen SD. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost 2011; 9: 185-91.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 185-191
-
-
Grove, E.L.1
Hvas, A.M.2
Mortensen, S.B.3
Larsen, S.B.4
Kristensen, S.D.5
-
22
-
-
33846235920
-
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
-
Hovens MM, Snoep JD, Eikelboom JC, van der Bom JG, Mertens BJ, Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J 2007; 153: 175-81.
-
(2007)
Am Heart J
, vol.153
, pp. 175-181
-
-
Hovens, M.M.1
Snoep, J.D.2
Eikelboom, J.C.3
van der Bom, J.G.4
Mertens, B.J.5
Huisman, M.V.6
-
23
-
-
70350459370
-
Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis
-
Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009; 102: 248-57.
-
(2009)
Thromb Haemost
, vol.102
, pp. 248-257
-
-
Jennings, L.K.1
-
24
-
-
0035312545
-
The effect of aspirin on C-reactive protein as a marker of risk in unstable angina
-
Kennon S, Price CP, Mills PG, Ranjadayalan K. The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. J Am Coll Cardiol 2001; 37; 1266-70.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 1266-1270
-
-
Kennon, S.1
Price, C.P.2
Mills, P.G.3
Ranjadayalan, K.4
-
25
-
-
38949119325
-
Aspirin "resistance" and the risk of cardiovascular morbidity: Systematic review and meta-analysis
-
Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and the risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008; 336: 195-8.
-
(2008)
BMJ
, vol.336
, pp. 195-198
-
-
Krasopoulos, G.1
Brister, S.J.2
Beattie, W.S.3
Buchanan, M.R.4
-
26
-
-
70450189795
-
Inflammation in atherosclerosis: From pathophysiology to practice
-
Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-38.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2129-2138
-
-
Libby, P.1
Ridker, P.M.2
Hansson, G.K.3
-
27
-
-
34547760330
-
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
-
Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007; 28: 1702-08.
-
(2007)
Eur Heart J
, vol.28
, pp. 1702-1708
-
-
Lordkipanidzé, M.1
Pharand, C.2
Schampaert, E.3
Turgeon, J.4
Palisaitis, D.A.5
Diodati, J.G.6
-
28
-
-
77950405789
-
Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages
-
Lu L, Liu H, Peng J, Gan L, Shen L, Zhang Q, Li L, Zhang L, Su C, Jiang Y. Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages. Lipids Health Dis 2010; 9: 16.
-
(2010)
Lipids Health Dis
, vol.9
, pp. 16
-
-
Lu, L.1
Liu, H.2
Peng, J.3
Gan, L.4
Shen, L.5
Zhang, Q.6
Li, L.7
Zhang, L.8
Su, C.9
Jiang, Y.10
-
29
-
-
33746218509
-
Platelet inhibition beyond conventional antiplatelet agents: Expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors
-
Malinin AI, Ong S, Makarov LM, Petukhova EY, Serebruany VL. Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors. Int J Clin Pract 2006, 60: 993-1002.
-
(2006)
Int J Clin Pract
, vol.60
, pp. 993-1002
-
-
Malinin, A.I.1
Ong, S.2
Makarov, L.M.3
Petukhova, E.Y.4
Serebruany, V.L.5
-
30
-
-
28444484957
-
Cyclooxygenase-1 haplotype modulates platelet response to aspirin
-
Maree AO, Curtin RJ, Chubb A, Dolan C, Cox D, O'Brien J, Crean P, Shields DC, Fitzgerald DJ. Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost 2005; 3: 2340-5.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2340-2345
-
-
Maree, A.O.1
Curtin, R.J.2
Chubb, A.3
Dolan, C.4
Cox, D.5
O'Brien, J.6
Crean, P.7
Shields, D.C.8
Fitzgerald, D.J.9
-
31
-
-
34248371253
-
Clinical aspects of platelet inhibitors and thrombus formation
-
Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res 2007; 100: 1261-75.
-
(2007)
Circ Res
, vol.100
, pp. 1261-1275
-
-
Meadows, T.A.1
Bhatt, D.L.2
-
32
-
-
80053178845
-
Aspirin resistance: Fact or fiction? A point of view
-
Mehta JL, Mohandas B. Aspirin resistance: Fact or fiction? A point of view. World J Cardiol 2010; 26: 280-8.
-
(2010)
World J Cardiol
, vol.26
, pp. 280-288
-
-
Mehta, J.L.1
Mohandas, B.2
-
33
-
-
17144396926
-
Platelet function testing in cardiovascular diseases
-
Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004; 110: e489-e93.
-
(2004)
Circulation
, vol.110
-
-
Michelson, A.D.1
-
34
-
-
24944474901
-
Aspirin resistance: Position paper of the Working Group on Aspirin Resistance
-
Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 2005; 3: 1309-11.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1309-1311
-
-
Michelson, A.D.1
Cattaneo, M.2
Eikelboom, J.W.3
Gurbel, P.4
Kottke-Marchant, K.5
Kunicki, T.J.6
Pulcinelli, F.M.7
Cerletti, C.8
Rao, A.K.9
-
35
-
-
67650756579
-
Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease
-
Muir AR, McMullin MF, Patterson C, McKeown PP. Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease. Heart 2009; 95: 1225-9.
-
(2009)
Heart
, vol.95
, pp. 1225-1229
-
-
Muir, A.R.1
McMullin, M.F.2
Patterson, C.3
McKeown, P.P.4
-
36
-
-
33646761285
-
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: Involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients
-
Ohmori T, Yatomi Y, Nonaka T, Kobayashi Y, Madoiwa S, Mimuro J, Ozaki Y, Sakata Y. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost 2006; 4: 1271-8.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 1271-1278
-
-
Ohmori, T.1
Yatomi, Y.2
Nonaka, T.3
Kobayashi, Y.4
Madoiwa, S.5
Mimuro, J.6
Ozaki, Y.7
Sakata, Y.8
-
37
-
-
0034739462
-
Direct proinflammatory effect of C-reactive protein on human endothelial cells
-
Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-8.
-
(2000)
Circulation
, vol.102
, pp. 2165-2168
-
-
Pasceri, V.1
Willerson, J.T.2
Yeh, E.T.3
-
38
-
-
0019988413
-
Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
-
Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69: 1366-72.
-
(1982)
J Clin Invest
, vol.69
, pp. 1366-1372
-
-
Patrignani, P.1
Filabozzi, P.2
Patrono, C.3
-
39
-
-
0141851094
-
Aspirin resistance: Definition, mechanism and clinical read-out
-
Patrono C. Aspirin resistance: definition, mechanism and clinical read-out. Thromb Haemost 2003; 1: 1710-3.
-
(2003)
Thromb Haemost
, vol.1
, pp. 1710-1713
-
-
Patrono, C.1
-
42
-
-
0022526869
-
Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions
-
Rao GH, Escolar G, White JG. Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res 1986; 44: 65-74.
-
(1986)
Thromb Res
, vol.44
, pp. 65-74
-
-
Rao, G.H.1
Escolar, G.2
White, J.G.3
-
43
-
-
18144390229
-
Aspirin resistance: A fact or a myth?
-
Rao GH. Aspirin resistance: A fact or a myth? Exp Clin Cardiol 2005; 10: 17-20.
-
(2005)
Exp Clin Cardiol
, vol.10
, pp. 17-20
-
-
Rao, G.H.1
-
44
-
-
78649873511
-
Inconsistency of different methods for assessing ex-vivo platelet function: Relevance for the detection of aspirin resistance
-
Renda G, Zurro M, Malatesta G, Ruggieri B, De Caterina R. Inconsistency of different methods for assessing ex-vivo platelet function: relevance for the detection of aspirin resistance. Haematologica 2010; 95: 2095-101.
-
(2010)
Haematologica
, vol.95
, pp. 2095-2101
-
-
Renda, G.1
Zurro, M.2
Malatesta, G.3
Ruggieri, B.4
de Caterina, R.5
-
45
-
-
0021131707
-
Inhibition of platelet function by a controlled release acetylsalicylic acid formulation-single and chronic dosing studies
-
Roberts MS, McLeod LJ, Cossum PA, Vial JH. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation-single and chronic dosing studies. Eur J Clin Pharmacol 1984; 27: 67-74.
-
(1984)
Eur J Clin Pharmacol
, vol.27
, pp. 67-74
-
-
Roberts, M.S.1
McLeod, L.J.2
Cossum, P.A.3
Vial, J.H.4
-
47
-
-
79960117909
-
Randomized, quadruple crossover single-blind study on immediate action of chewed and unchewed low-dose acetylsalicylic acid tablets in healthy volunteers
-
Sai Y, Kusaka A, Imanishi K, Matsumoto M, Takahashi R, Sugimoto N, Sugama J, Anada T, Asakura H, Miyamoto K. Randomized, quadruple crossover single-blind study on immediate action of chewed and unchewed low-dose acetylsalicylic acid tablets in healthy volunteers. J Pharm Sci 2011; 100: 3884-91.
-
(2011)
J Pharm Sci
, vol.100
, pp. 3884-3891
-
-
Sai, Y.1
Kusaka, A.2
Imanishi, K.3
Matsumoto, M.4
Takahashi, R.5
Sugimoto, N.6
Sugama, J.7
Anada, T.8
Asakura, H.9
Miyamoto, K.10
-
48
-
-
70349580701
-
Aspirin resistance after CABG
-
Sanlioglu S, Tetik S, Sokullu O, Deniz H, Aydemir N, Yilmaz M, Arslan IY, Bilgen F. Aspirin resistance after CABG. Thorac Cardiovasc Surg 2009; 57: 281-5.
-
(2009)
Thorac Cardiovasc Surg
, vol.57
, pp. 281-285
-
-
Sanlioglu, S.1
Tetik, S.2
Sokullu, O.3
Deniz, H.4
Aydemir, N.5
Yilmaz, M.6
Arslan, I.Y.7
Bilgen, F.8
-
49
-
-
60049093774
-
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: Implications for aspirin "resistance"
-
Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, Davì G, Patrono C. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol 2009; 53: 667-77.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 667-677
-
-
Santilli, F.1
Rocca, B.2
de Cristofaro, R.3
Lattanzio, S.4
Pietrangelo, L.5
Habib, A.6
Pettinella, C.7
Recchiuti, A.8
Ferrante, E.9
Ciabattoni, G.10
Davì, G.11
Patrono, C.12
-
51
-
-
78649990318
-
Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease
-
Schwedhelm E, Bierend A, Maas R, Trinks R, Kom GD, Tsikas D, Böger RH. Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease. J Thromb Haemost 2010; 12: 2662-70.
-
(2010)
J Thromb Haemost
, vol.12
, pp. 2662-2670
-
-
Schwedhelm, E.1
Bierend, A.2
Maas, R.3
Trinks, R.4
Kom, G.D.5
Tsikas, D.6
Böger, R.H.7
-
52
-
-
79952557680
-
Monitoring of antiplatelet therapy. Current limitations, challenges and perspectives
-
Seidel H, Rahman MM, Scharf RE. Monitoring of antiplatelet therapy. Current limitations, challenges and perspectives. Hämostaseologie 2011; 31: 41-51.
-
(2011)
Hämostaseologie
, vol.31
, pp. 41-51
-
-
Seidel, H.1
Rahman, M.M.2
Scharf, R.E.3
-
53
-
-
67849087239
-
Aspirin resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study)
-
Shen H, Herzog W, Drolet M, Pakyz R, Newcomer S, Sack P, Karon H, Ryan KH, Zhao Y, Shi X, Mitchell BD, Shuldiner AR. Aspirin resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study). Am J Cardiol 2009; 104: 606-12.
-
(2009)
Am J Cardiol
, vol.104
, pp. 606-612
-
-
Shen, H.1
Herzog, W.2
Drolet, M.3
Pakyz, R.4
Newcomer, S.5
Sack, P.6
Karon, H.7
Ryan, K.H.8
Zhao, Y.9
Shi, X.10
Mitchell, B.D.11
Shuldiner, A.R.12
-
54
-
-
77749264545
-
Chronic stable coronary artery disease: Drugs vs. revascularization
-
Simoons ML, Windecker S. Chronic stable coronary artery disease: drugs vs. revascularization. Eur Heart J 2010; 31: 530-41.
-
(2010)
Eur Heart J
, vol.31
, pp. 530-541
-
-
Simoons, M.L.1
Windecker, S.2
-
55
-
-
0023816185
-
Diminished platelet residence time on active human atherosclerotic lesions in-vivo-evidence for an optimal dose of aspirin?
-
Sinzinger H, Kaliman J, Fitscha P, O'Grady J. Diminished platelet residence time on active human atherosclerotic lesions in-vivo-evidence for an optimal dose of aspirin? Prostaglandins Leukot Essent Fatty Acids 1988; 34: 88-93.
-
(1988)
Prostaglandins Leukot Essent Fatty Acids
, vol.34
, pp. 88-93
-
-
Sinzinger, H.1
Kaliman, J.2
Fitscha, P.3
O'Grady, J.4
-
56
-
-
0029092397
-
Thrombocyte function of healthy probands taking 50mg acetylsalicylic acid per day
-
Sinzinger H, Kritz H, Pirich C, Karanikas G, Kurtaran A, Banyai M, Peskar BA, Rehak P. Thrombocyte function of healthy probands taking 50mg acetylsalicylic acid per day. Wien Klin Wochenschr 1995; 107: 457-63.
-
(1995)
Wien Klin Wochenschr
, vol.107
, pp. 457-463
-
-
Sinzinger, H.1
Kritz, H.2
Pirich, C.3
Karanikas, G.4
Kurtaran, A.5
Banyai, M.6
Peskar, B.A.7
Rehak, P.8
-
57
-
-
34447503098
-
Association of laboratory-defined aspirin resistance with a high risk of recurrent cardiovascular events: A systematic review and meta-analysis
-
Snoep JD, Hovens MMC, Eikenboom JC, van der Bom JG, Huisman MV. Association of laboratory-defined aspirin resistance with a high risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 1593-9.
-
(2007)
Arch Intern Med
, vol.167
, pp. 1593-1599
-
-
Snoep, J.D.1
Hovens, M.M.C.2
Eikenboom, J.C.3
van der Bom, J.G.4
Huisman, M.V.5
-
58
-
-
33645215110
-
Endothelial function and inflammation in coronary artery disease
-
Tousoulis D, Charakida M, Stefanadis C. Endothelial function and inflammation in coronary artery disease. Heart 2006; 92: 441-4.
-
(2006)
Heart
, vol.92
, pp. 441-444
-
-
Tousoulis, D.1
Charakida, M.2
Stefanadis, C.3
-
59
-
-
79954609254
-
The assessment of aspirin resistance by using light transmission and multiple electrode aggregometry
-
Ulehlova J, Slavik L, Krcova V, Hutyra M, Galuszka J, Indrak K. The assessment of aspirin resistance by using light transmission and multiple electrode aggregometry. Int J Lab Hematol 2011; 33: 305-9.
-
(2011)
Int J Lab Hematol
, vol.33
, pp. 305-309
-
-
Ulehlova, J.1
Slavik, L.2
Krcova, V.3
Hutyra, M.4
Galuszka, J.5
Indrak, K.6
-
60
-
-
18544385812
-
Effects of entericcoated, low-dose aspirin on parameters of platelet function
-
Van Hecken A, Juliano ML, Depre M, Lepeleire ID, Arnout J, Dynder A, Wildonger L, Petty KJ, Gottesdiener K, De Hoon JN. Effects of entericcoated, low-dose aspirin on parameters of platelet function. Aliment Pharmacol Ther 2002; 16: 1683-8.
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 1683-1688
-
-
van Hecken, A.1
Juliano, M.L.2
Depre, M.3
Lepeleire, I.D.4
Arnout, J.5
Dynder, A.6
Wildonger, L.7
Petty, K.J.8
Gottesdiener, K.9
de Hoon, J.N.10
-
61
-
-
0015237292
-
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
-
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971; 231: 232-5.
-
(1971)
Nature New Biol
, vol.231
, pp. 232-235
-
-
Vane, J.R.1
-
62
-
-
0141885287
-
C-reactive protein decreases prostacyclin release from human aortic endothelial cells
-
Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation 2003; 108: 1676-8.
-
(2003)
Circulation
, vol.108
, pp. 1676-1678
-
-
Venugopal, S.K.1
Devaraj, S.2
Jialal, I.3
-
63
-
-
33644886913
-
Aspirin and clopidogrel resistance: An emerging clinical entity
-
Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 2006; 27: 647-54.
-
(2006)
Eur Heart J
, vol.27
, pp. 647-654
-
-
Wang, T.H.1
Bhatt, D.L.2
Topol, E.J.3
-
64
-
-
33746087046
-
C-reactive protein promotes platelet adhesion to endothelial cells: A potential pathway in atherothrombosis
-
Yaron G, Brill A, Dashevsky O, Yosef-Levi IM, Grad E, Danenberg HD, Varon D. C-reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis. Br J Haematol 2006; 134: 426-41.
-
(2006)
Br J Haematol
, vol.134
, pp. 426-441
-
-
Yaron, G.1
Brill, A.2
Dashevsky, O.3
Yosef-Levi, I.M.4
Grad, E.5
Danenberg, H.D.6
Varon, D.7
|